Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 151

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 151
---
 and other significant decisions with respect to such regulatory approvals and consider comments or suggestions provided by STAAR with respect to such regulatory approvals in good faith. Stockholder Meeting As promptly as reasonably practicable following the earliest of (i) the date on which the SEC confirms that it has no further comments to this proxy statement, (ii) the receipt by STAAR of confirmation from the SEC that it will not be reviewing this proxy statement, or (iii) if the SEC has failed to affirmatively notify STAAR that it will or will not be reviewing the proxy statement within ten (10) calendar days after the initial filing of this proxy -92-

statement with the SEC, the tenth (10th) day after such filing (the “clearance date”), STAAR has agreed to establish a record date for, duly call, give notice of, convene, and hold the Special Meeting for the purpose of seeking the Stockholder Approval and approval of the Compensation Proposal and to use reasonable best efforts to cause the Special Meeting to be held no later than the 45th day following the clearance date and to obtain the Stockholder Approval. Stockholder Litigation STAAR has agreed to promptly notify Alcon in writing, and keep Alcon reasonably and promptly informed, of any actions, suits, claims, investigations or proceedings instituted or threatened against STAAR or its directors, officers, by any holders of shares of STAAR common stock, relating to the Merger Agreement or the transactions contemplated by the Merger Agreement. STAAR has also agreed (i) to give Alcon the right to participate in (but not control) and consult with STAAR regarding the defense, prosecution, settlement or compromise of any such actions, suits, claims, investigations or proceedings and (ii) not to settle, compromise, or agree to settle or compromise, any such actions, suits, claims, investigations or proceedings without Alcon’s written consent (not to be unreasonably withheld, conditioned, or delayed). Other Covenants The Merger Agreement contains other covenants, including those relating to:

| • |     | access to information; |

| • |     | the preparation of this proxy statement; |

| • |     | anti-takeover statutes and regulations; |

| • |     | public announcements; |

| • |     | stock exchange delisting and deregistration; |

| • |     | matters related to Section 16 of the Exchange Act; and |

| • |     | notification of certain events. |

Conditions to the Closing of the Mer